Cargando…
Rapid targeted gene disruption in Bacillus anthracis
BACKGROUND: Anthrax is a zoonotic disease recognized to affect herbivores since Biblical times and has the widest range of susceptible host species of any known pathogen. The ease with which the bacterium can be weaponized and its recent deliberate use as an agent of terror, have highlighted the imp...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848504/ https://www.ncbi.nlm.nih.gov/pubmed/24047152 http://dx.doi.org/10.1186/1472-6750-13-72 |
_version_ | 1782293767250771968 |
---|---|
author | Saldanha, Roland J Pemberton, Adin Shiflett, Patrick Perutka, Jiri Whitt, Jacob T Ellington, Andrew Lambowitz, Alan M Kramer, Ryan Taylor, Deborah Lamkin, Thomas J |
author_facet | Saldanha, Roland J Pemberton, Adin Shiflett, Patrick Perutka, Jiri Whitt, Jacob T Ellington, Andrew Lambowitz, Alan M Kramer, Ryan Taylor, Deborah Lamkin, Thomas J |
author_sort | Saldanha, Roland J |
collection | PubMed |
description | BACKGROUND: Anthrax is a zoonotic disease recognized to affect herbivores since Biblical times and has the widest range of susceptible host species of any known pathogen. The ease with which the bacterium can be weaponized and its recent deliberate use as an agent of terror, have highlighted the importance of gaining a deeper understanding and effective countermeasures for this important pathogen. High quality sequence data has opened the possibility of systematic dissection of how genes distributed on both the bacterial chromosome and associated plasmids have made it such a successful pathogen. However, low transformation efficiency and relatively few genetic tools for chromosomal manipulation have hampered full interrogation of its genome. RESULTS: Group II introns have been developed into an efficient tool for site-specific gene inactivation in several organisms. We have adapted group II intron targeting technology for application in Bacillus anthracis and generated vectors that permit gene inactivation through group II intron insertion. The vectors developed permit screening for the desired insertion through PCR or direct selection of intron insertions using a selection scheme that activates a kanamycin resistance marker upon successful intron insertion. CONCLUSIONS: The design and vector construction described here provides a useful tool for high throughput experimental interrogation of the Bacillus anthracis genome and will benefit efforts to develop improved vaccines and therapeutics. |
format | Online Article Text |
id | pubmed-3848504 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38485042013-12-04 Rapid targeted gene disruption in Bacillus anthracis Saldanha, Roland J Pemberton, Adin Shiflett, Patrick Perutka, Jiri Whitt, Jacob T Ellington, Andrew Lambowitz, Alan M Kramer, Ryan Taylor, Deborah Lamkin, Thomas J BMC Biotechnol Methodology Article BACKGROUND: Anthrax is a zoonotic disease recognized to affect herbivores since Biblical times and has the widest range of susceptible host species of any known pathogen. The ease with which the bacterium can be weaponized and its recent deliberate use as an agent of terror, have highlighted the importance of gaining a deeper understanding and effective countermeasures for this important pathogen. High quality sequence data has opened the possibility of systematic dissection of how genes distributed on both the bacterial chromosome and associated plasmids have made it such a successful pathogen. However, low transformation efficiency and relatively few genetic tools for chromosomal manipulation have hampered full interrogation of its genome. RESULTS: Group II introns have been developed into an efficient tool for site-specific gene inactivation in several organisms. We have adapted group II intron targeting technology for application in Bacillus anthracis and generated vectors that permit gene inactivation through group II intron insertion. The vectors developed permit screening for the desired insertion through PCR or direct selection of intron insertions using a selection scheme that activates a kanamycin resistance marker upon successful intron insertion. CONCLUSIONS: The design and vector construction described here provides a useful tool for high throughput experimental interrogation of the Bacillus anthracis genome and will benefit efforts to develop improved vaccines and therapeutics. BioMed Central 2013-09-18 /pmc/articles/PMC3848504/ /pubmed/24047152 http://dx.doi.org/10.1186/1472-6750-13-72 Text en Copyright © 2013 Saldanha et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Article Saldanha, Roland J Pemberton, Adin Shiflett, Patrick Perutka, Jiri Whitt, Jacob T Ellington, Andrew Lambowitz, Alan M Kramer, Ryan Taylor, Deborah Lamkin, Thomas J Rapid targeted gene disruption in Bacillus anthracis |
title | Rapid targeted gene disruption in Bacillus anthracis |
title_full | Rapid targeted gene disruption in Bacillus anthracis |
title_fullStr | Rapid targeted gene disruption in Bacillus anthracis |
title_full_unstemmed | Rapid targeted gene disruption in Bacillus anthracis |
title_short | Rapid targeted gene disruption in Bacillus anthracis |
title_sort | rapid targeted gene disruption in bacillus anthracis |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848504/ https://www.ncbi.nlm.nih.gov/pubmed/24047152 http://dx.doi.org/10.1186/1472-6750-13-72 |
work_keys_str_mv | AT saldanharolandj rapidtargetedgenedisruptioninbacillusanthracis AT pembertonadin rapidtargetedgenedisruptioninbacillusanthracis AT shiflettpatrick rapidtargetedgenedisruptioninbacillusanthracis AT perutkajiri rapidtargetedgenedisruptioninbacillusanthracis AT whittjacobt rapidtargetedgenedisruptioninbacillusanthracis AT ellingtonandrew rapidtargetedgenedisruptioninbacillusanthracis AT lambowitzalanm rapidtargetedgenedisruptioninbacillusanthracis AT kramerryan rapidtargetedgenedisruptioninbacillusanthracis AT taylordeborah rapidtargetedgenedisruptioninbacillusanthracis AT lamkinthomasj rapidtargetedgenedisruptioninbacillusanthracis |